About: covid:PMC7322703

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7322703 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Aguilar, Gerardo Rodriguez, Alejandro Ramirez, Paula Martín-Loeches, Ignacio Ferrer, Ricard Diaz, Emili Borges, Marcio Maseda, Emilio Nieto, Mercedes Nuvials, Francisco Soriano, Cruz Veganzones, Javier Vidal-Cortés, Pablo Zaragoza, Rafael
is schema:about of	named entity 'TREATMENT' named entity 'ICU' named entity 'respiratory support' named entity 'antibiotic' named entity 'multidrug-resistant' named entity 'case-control study' named entity '95% CI' named entity 'antibiotic treatment' named entity 'infection' named entity 'infection' named entity 'prognosis' named entity 'length of stay' named entity 'risk factors' named entity 'enterobacteria' named entity 'risk factors' named entity 'VAP' named entity 'C-reactive protein' named entity 'antimicrobials' named entity 'VAP' named entity 'ICUs' named entity 'adverse effects' named entity 'ECMO' named entity 'VAP' named entity 'HAP' named entity 'VAT' named entity 'microbiological' named entity 'antibiotic' named entity 'adjunctive therapy' named entity 'HAP' named entity 'VAT' named entity 'infection' named entity 'antimicrobials' named entity 'nosocomial infection' named entity 'ceftriaxone' named entity 'microbiology' named entity 'VAP' named entity 'respiratory support' named entity 'VAP' named entity 'placebo-controlled' named entity 'preventive measures' named entity 'Enterobacteriaceae' named entity 'ICU' named entity 'P. aeruginosa' named entity 'biomarkers' named entity 'critically ill patients' named entity 'empirical treatment' named entity 'risk of death' named entity 'risk factor' named entity 'antibiotic treatment' named entity 'bacteria' named entity 'extracorporeal membrane oxygenation' named entity 'statistical significance' named entity 'nosocomial pneumonia' named entity 'length of stay' named entity 'ICU' named entity 'pathogens' named entity 'clinical trial' named entity 'empirical treatment' named entity 'aerosolized' named entity 'VAT' named entity 'intensive care unit' named entity 'P. aeruginosa' named entity 'lower respiratory tract' named entity 'Europe' named entity 'VAP' named entity 'VAT' named entity 'diabetes mellitus' named entity 'tigecycline' named entity 'nosocomial pneumonia' named entity 'procalcitonin' named entity 'hospital-acquired pneumonia' named entity 'VAP' named entity 'meropenem' named entity 'HAP' named entity 'HAP' named entity 'pseudomonal' named entity 'clinical trials' named entity 'ICU' named entity 'Acinetobacter baumannii' named entity 'HAP' named entity 'hypotension' named entity 'survival rates' named entity 'Rescue therapy' named entity 'VAP' named entity 'polymerase chain reaction' named entity 'septic shock'

Attributes

Values

Creator

Aguilar, Gerardo
Rodriguez, Alejandro
Ramirez, Paula
Martín-Loeches, Ignacio
Ferrer, Ricard
Diaz, Emili
Borges, Marcio
Maseda, Emilio
Nieto, Mercedes
Nuvials, Francisco
Soriano, Cruz
Veganzones, Javier
Vidal-Cortés, Pablo
Zaragoza, Rafael

is schema:about of

named entity 'TREATMENT'
named entity 'ICU'
named entity 'respiratory support'
named entity 'antibiotic'
named entity 'multidrug-resistant'
named entity 'case-control study'
named entity '95% CI'
named entity 'antibiotic treatment'
named entity 'infection'
named entity 'infection'
named entity 'prognosis'
named entity 'length of stay'
named entity 'risk factors'
named entity 'enterobacteria'
named entity 'risk factors'
named entity 'VAP'
named entity 'C-reactive protein'
named entity 'antimicrobials'
named entity 'VAP'
named entity 'ICUs'
named entity 'adverse effects'
named entity 'ECMO'
named entity 'VAP'
named entity 'HAP'
named entity 'VAT'
named entity 'microbiological'
named entity 'antibiotic'
named entity 'adjunctive therapy'
named entity 'HAP'
named entity 'VAT'
named entity 'infection'
named entity 'antimicrobials'
named entity 'nosocomial infection'
named entity 'ceftriaxone'
named entity 'microbiology'
named entity 'VAP'
named entity 'respiratory support'
named entity 'VAP'
named entity 'placebo-controlled'
named entity 'preventive measures'
named entity 'Enterobacteriaceae'
named entity 'ICU'
named entity 'P. aeruginosa'
named entity 'biomarkers'
named entity 'critically ill patients'
named entity 'empirical treatment'
named entity 'risk of death'
named entity 'risk factor'
named entity 'antibiotic treatment'
named entity 'bacteria'
named entity 'extracorporeal membrane oxygenation'
named entity 'statistical significance'
named entity 'nosocomial pneumonia'
named entity 'length of stay'
named entity 'ICU'
named entity 'pathogens'
named entity 'clinical trial'
named entity 'empirical treatment'
named entity 'aerosolized'
named entity 'VAT'
named entity 'intensive care unit'
named entity 'P. aeruginosa'
named entity 'lower respiratory tract'
named entity 'Europe'
named entity 'VAP'
named entity 'VAT'
named entity 'diabetes mellitus'
named entity 'tigecycline'
named entity 'nosocomial pneumonia'
named entity 'procalcitonin'
named entity 'hospital-acquired pneumonia'
named entity 'VAP'
named entity 'meropenem'
named entity 'HAP'
named entity 'HAP'
named entity 'pseudomonal'
named entity 'clinical trials'
named entity 'ICU'
named entity 'Acinetobacter baumannii'
named entity 'HAP'
named entity 'hypotension'
named entity 'survival rates'
named entity 'Rescue therapy'
named entity 'VAP'
named entity 'polymerase chain reaction'
named entity 'septic shock'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software